Informing scale-up and resource allocation: the use of economic analysis
Stakeholders' opinions and expectations of the Global Fund and their potential economic implications
Financing the response to AIDS: some fiscal and macroeconomic considerations
The economics of scaling up: cost estimation for HIV/AIDS interventions
Assessing efficiency and costs of scaling up HIV treatment
Changing cost of HIV interventions in the context of scaling-up in India
How can we calculate the “E” in “CEA”?
Universal access to HIV treatment in developing countries: going beyond the misinterpretations of the ‘cost-effectiveness’ algorithm
Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework
Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries
The economic impacts of HIV/AIDS on households and economies
Methodological issues in the study of the socioeconomic consequences of HIV/AIDS
Assessing the economic impact of HIV/AIDS on Nigerian households: a propensity score matching approach
Confirming the impact of HIV/AIDS epidemics on household vulnerability in Asia: the case of Cambodia
Macroeconomic and household-level impacts of HIV/AIDS in Botswana
Combining evidence for access to and benefits from antiretroviral treatment to inform planning
Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans
Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa
Costs and benefits of HAART for patients with HIV in a public hospital in Mexico
Evaluating the impact of antiretroviral therapy on HIV transmission
Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries